Accelerated Evolution Biotechnologies Claims to Have a Breakthrough Cancer Cure
Aridor, chairman of the board of AEBi and CEO Dr. Ilan Morad, say the AEBi anti-cancer treatment, which they call MuTaTo (multi-target toxin) is essentially on the scale of a cancer antibiotic – a disruption technology of the highest order. They are using peptides. MuTaTo is using a combination of several cancer-targeting peptides for each …